AAM Biotechnology Opps 2021-1 RE
Fund
BIOACX
Price as of:
$11.35
+ $0.02
+ 0.21%
Primary Theme
N/A
fund company
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
N/A
1 yr return
N/A
3 Yr Avg Return
N/A
5 Yr Avg Return
N/A
Net Assets
$N/A
Holdings in Top 10
40.6%
52 WEEK LOW AND HIGH
$11.3
$9.27
$11.76
Expenses
OPERATING FEES
Expense Ratio 0.38%
SALES FEES
Front Load 0.00%
Deferred Load 2.25%
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
N/A
Fund Classification
Fund Type
Unknown
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
BIOACX - Profile
Distributions
- YTD Total Return N/A
- 3 Yr Annualized Total Return N/A
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.0%
- Dividend Distribution Frequency Semi-Annually
Fund Details
-
Legal NameBiotechnology Opportunities Portfolio, Series 2021-1
-
Fund Family NameAdvisors Asset Management, Inc.
-
Inception DateApr 07, 2021
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUnited States
Fund Description
BIOACX - Performance
Return Ranking - Trailing
Period | BIOACX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -25.6% | 23.4% | N/A |
1 Yr | N/A | -30.0% | 21.8% | N/A |
3 Yr | N/A* | -18.7% | 19.7% | N/A |
5 Yr | N/A* | -14.7% | 15.3% | N/A |
10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Return Ranking - Calendar
Period | BIOACX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -53.9% | 11.7% | N/A |
2022 | N/A | -22.3% | 18.5% | N/A |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 26.9% | N/A |
Total Return Ranking - Trailing
Period | BIOACX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -41.2% | 23.4% | N/A |
1 Yr | 17.3% | -30.0% | 28.3% | 4.52% |
3 Yr | N/A* | -18.7% | 19.7% | N/A |
5 Yr | N/A* | -14.7% | 15.3% | N/A |
10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | BIOACX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -53.9% | 11.7% | N/A |
2022 | N/A | -22.3% | 18.5% | N/A |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 26.9% | N/A |
NAV & Total Return History
BIOACX - Holdings
Concentration Analysis
BIOACX | Category Low | Category High | BIOACX % Rank | |
---|---|---|---|---|
Net Assets | N/A | 732 K | 46.2 B | N/A |
Number of Holdings | 36 | 21 | 473 | 88.48% |
Net Assets in Top 10 | 4.06 K | 2.18 K | 21.6 B | 99.48% |
Weighting of Top 10 | 40.56% | 12.3% | 80.8% | 71.20% |
Top 10 Holdings
- BioNTech SE ADR 6.96%
- Moderna Inc 6.43%
- Biohaven Pharmaceutical Holding Co Ltd 4.68%
- Intellia Therapeutics Inc 4.33%
- NovoCure Ltd 4.09%
- Dicerna Pharmaceuticals Inc 3.53%
- CRISPR Therapeutics AG 3.26%
- Regeneron Pharmaceuticals Inc 3.01%
- Novavax Inc 3.00%
- Repligen Corp 2.98%
Asset Allocation
Weighting | Return Low | Return High | BIOACX % Rank | |
---|---|---|---|---|
Stocks | 100.00% | 85.37% | 106.13% | 21.47% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 96.86% |
Other | 0.00% | -22.99% | 3.38% | 91.10% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 96.86% |
Cash | 0.00% | -0.10% | 9.01% | 97.38% |
Bonds | 0.00% | 0.00% | 12.39% | 96.86% |
Stock Sector Breakdown
Weighting | Return Low | Return High | BIOACX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 47.64% |
Utilities | 0.00% | 0.00% | 0.00% | 96.86% |
Technology | 0.00% | 0.00% | 22.69% | 97.38% |
Real Estate | 0.00% | 0.00% | 7.13% | 96.86% |
Industrials | 0.00% | 0.00% | 7.02% | 97.38% |
Financial Services | 0.00% | 0.00% | 1.85% | 97.91% |
Energy | 0.00% | 0.00% | 0.00% | 96.86% |
Communication Services | 0.00% | 0.00% | 9.11% | 96.86% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 97.38% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 97.38% |
Basic Materials | 0.00% | 0.00% | 14.83% | 97.91% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | BIOACX % Rank | |
---|---|---|---|---|
US | 87.74% | 53.67% | 104.41% | 42.93% |
Non US | 12.26% | 0.00% | 45.40% | 48.17% |
BIOACX - Expenses
Operational Fees
BIOACX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.38% | 0.08% | 3.13% | 87.11% |
Management Fee | N/A | 0.00% | 1.25% | N/A |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
BIOACX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | 0.00% | 0.00% | 5.75% | 100.00% |
Deferred Load | 2.25% | 1.00% | 5.00% | 35.29% |
Trading Fees
BIOACX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
BIOACX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | N/A | 0.00% | 238.00% | N/A |
BIOACX - Distributions
Dividend Yield Analysis
BIOACX | Category Low | Category High | BIOACX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 2.44% | 95.41% |
Dividend Distribution Analysis
BIOACX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Semi-Annually | Annually | Quarterly | Annually |
Net Income Ratio Analysis
BIOACX | Category Low | Category High | BIOACX % Rank | |
---|---|---|---|---|
Net Income Ratio | N/A | -2.54% | 1.92% | N/A |
Capital Gain Distribution Analysis
BIOACX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually |